PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation
•PRMT6 is downregulated in HCC and correlates negatively with aggressive HCC •PRMT6 silencing drives cancer stemness in vitro and patient-derived organoids •PRMT6 binds to CRAF,